WOOLSEY PHARMACEUTICALS is a repurposed therapeutics company targeting neurodegenerative diseases.
Neurodegenerative disease is an umbrella term for a range of conditions which primarily affect the neurons – the building blocks of the nervous system – in the human brain. Many neurodegenerative diseases – including amyotrophic lateral sclerosis (ALS), Parkinson’s disease, Alzheimer’s disease, Huntington’s disease and Multiple Sclerosis – occur as a result of the progressive death of neurons in different regions of the nervous system.
Degenerative nerve diseases affect a number of the body’s activities, such as balance, movement, talking, breathing, heart function and memory. Many of these diseases are genetic. Most have no effective cure.